跳至主要内容
临床试验/DRKS00019834
DRKS00019834已完成不适用

CSF-analysis in SMA - searching biomarkers in CSF of patients with spinal muscular atrophy via proteomic analysis and neurofilament-ELISA - SMA-CSF

niversitätsklinikum Freiburg0 个研究点目标入组 31 人开始时间: 2022年4月5日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
31

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
0 Years 至 17 Years(—)
性别
All

入选标准

  • Genetically proven 5q spinal muscular atrophy of all subtypes
  • Collection of CSF as part of a medically indicated lumbar puncture (e.g. intrathecal therapy with Nusinersen)
  • Written declaration of consent from the legal guardians for the scientific use of data and samples from the corresponding biobanks
  • Written declaration of consent from the patient to the scientific use of data and samples from the corresponding biobanks, provided that he is able to understand the nature, significance and scope of the study in terms of age and stage of development and to determine his will accordingly.

排除标准

  • Known intracranial or intraspinal malignancy

研究者

相似试验